Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene
Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers.
Cheung HW, Du J, Boehm JS, He F, Weir BA, Wang X, Butaney M, Sequist LV, Luo B, Engelman JA, Root DE, Meyerson M, Golub TR, Janne PA, Hahn WC
Cancer Discov. 2011 Dec;1(7):608-25. doi: 10.1158/2159-8290.CD-11-0046. Epub 2011 Oct 17.
PubMed Article

Plasmids from Article

ID Plasmid Purpose
196015pLenti6.3_CRKL-silent-V5Expresses CRKL-silent, V5 tagged
196016pLenti6.3_CRKL-Y207F-V5Expresses CRKL Y207F, V5 tagged
196017pLenti6.3_CRKL-W160L-V5Expresses CRKL W160L, V5 tagged
196018pLenti6.3_CRKL-WT-V5Expresses CRKL WT, V5 tagged
196019pWzl_CRKL-W275LExpresses CRKL W275L
196020pWzl_CRKL-W160L+Y207FExpresses Expresses CRKL W160L + Y207F
196021pWzl_CRKL-W160L+W275LExpresses CRKL W160L + W275L
196022pWzl_CRKL-Y207F+W275LExpresses CRKL Y207F + W275L
196023plx304_CRKL-open-V5Expresses CRKL open, V5 tagged

Antibodies from Article